AAAAAA

   
Results: 1-11 |
Results: 11
Special issue: Neuropathology of severe mental illness: Studies from the Stanley Foundation Neuropathology Consortium - Foreword
Authors: Knable, MB Webster, MJ
Citation: Mb. Knable et Mj. Webster, Special issue: Neuropathology of severe mental illness: Studies from the Stanley Foundation Neuropathology Consortium - Foreword, BRAIN RES B, 55(5), 2001, pp. 567-568
Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium
Authors: Knable, MB Torrey, EF Webster, MJ Bartko, JJ
Citation: Mb. Knable et al., Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium, BRAIN RES B, 55(5), 2001, pp. 651-659
Topiramate for bulimia nervosa in epilepsy
Authors: Knable, MB
Citation: Mb. Knable, Topiramate for bulimia nervosa in epilepsy, AM J PSYCHI, 158(2), 2001, pp. 322-323
Neuropharmacological studies with SPECT in neuropsychiatric disorders
Authors: Heinz, A Jones, DW Raedler, T Coppola, R Knable, MB Weinberger, DR
Citation: A. Heinz et al., Neuropharmacological studies with SPECT in neuropsychiatric disorders, NUCL MED BI, 27(7), 2000, pp. 677-682
In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia
Authors: Raedler, TJ Knable, MB Jones, DW Lafargue, T Urbina, RA Egan, MF Pickar, D Weinberger, DR
Citation: Tj. Raedler et al., In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia, NEUROPSYCH, 23(1), 2000, pp. 56-68
Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder
Authors: Bayer, TA Schramm, M Feldmann, N Knable, MB Falkai, P
Citation: Ta. Bayer et al., Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder, PROG NEUR-P, 24(6), 2000, pp. 881-888
In vivo determination of striatal dopamine D-2 receptor occupancy in patients treated with olanzapine
Authors: Raedler, TJ Knable, MB Lafargue, T Urbina, RA Egan, MF Pickar, D Weinberger, DR
Citation: Tj. Raedler et al., In vivo determination of striatal dopamine D-2 receptor occupancy in patients treated with olanzapine, PSYCH RES-N, 90(2), 1999, pp. 81-90
Are schizophrenia and bipolar disorder one disease or two? Introduction tothe symposium
Authors: Torrey, EF Knable, MB
Citation: Ef. Torrey et Mb. Knable, Are schizophrenia and bipolar disorder one disease or two? Introduction tothe symposium, SCHIZOPHR R, 39(2), 1999, pp. 93-94
Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection
Authors: Knable, MB
Citation: Mb. Knable, Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection, SCHIZOPHR R, 39(2), 1999, pp. 149-152
The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia
Authors: Bertolino, A Knable, MB Saunders, RC Callicott, JH Kolachana, B Mattay, VS Bachevalier, J Frank, JA Egan, M Weinberger, DR
Citation: A. Bertolino et al., The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia, BIOL PSYCHI, 45(6), 1999, pp. 660-667
Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia
Authors: Schramm, M Falkai, P Feldmann, N Knable, MB Bayer, TA
Citation: M. Schramm et al., Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia, NEUROSCI L, 257(2), 1998, pp. 65-68
Risultati: 1-11 |